Drug Eluting Stent Trials
|
Drug Eluting Stent Trials |
|
ARCHER Stenting of the internal carotid artery using the Guidant ACCULINK™ Carotid Stent System with or without the ACCUNET™ Embolic Protection System BASKET Basel Stent Cost-Effectiveness (BASKET) Trial DELIVER paclitaxel-coated RX ACHIEVE™ Drug-Eluting Coronary Stent System (CSS) vs. the metallic MULTI-LINK RX PENTA™ CSS in patients with de novo coronary lesions. DIABETES Sirolimus-eluting stents vs bare metal stents among diabetic patients undergoing PCI DIRECT direct stenting vs predilatation in patients receiving sirolimus-eluting stents for treatment of single, de novo lesions LONG DES II Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions NORDIC Bifurcation Trial Presented at TCT 2006 PASSION Taxus vs Bare Metal stent in STEMI PROGRESS 1: First in man bioabsorbable stent |
RAVEL Long-term (1 term) Sirolimus releasing stents (Cypher) vs standard uncoated stents in patients undergoing PCI REALITY Sirolimus-eluting stents (Cypher) vs paclitaxel-eluting stents (Taxus) among patients with de novo coronary lesions *by Dr. Morice SCANDSTENT Cypher stenting in complex disease SESAMI Sirolimus Stent vs Bare Stent in Acute Myocardial Infarction Trial SIRIUS Efficacy of sirolimus-eluting coated stent in native coronary lesions *Results presented at EURO PCR 2002 SIRIUS Efficacy of sirolimus-eluting coated stent in native coronary lesions *Results presented at TCT 2002 SIRIUS Economic Results Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses *by David Cohen, MD Canadian SIRIUS Canadian study of sirolimus-eluting stents vs uncoated stents SIRTAX Randomized, single center trial of Cypher vs Taxus, no industry support |
TAXUS 2 Moderate release paclitaxel-eluting stent vs bare stent in de novo lesions *Presented at TCT 2002 TAXUS 2 Slow release paclitaxel-eluting stent vs bare stent in de novo lesions *Presented at TCT 2002 TAXUS 2 and 4 Two Year Results TAXUS IV Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesions TAXUS IV 2 Year follow up data TAXUS V Efficacy of the slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single complex coronary lesions *Source: Gregg Stone, MD and Jeffrey Popma, MD Taxus ATLAS Evaluation of TAXUS Liberté vs. TAXUS Express Trial TAXUS V ISR Trial of Taxus stent vs brachytherapy for in stent restenosis TYPHOON Cypher vs Bare metal stent in STEMI
|
